Minimal hepatic encephalopathy in hepatosplenic schistosomiasis: High prevalence and association with portosystemic shunts in a Brazilian cross-sectional study [0.03%]
巴西横断面研究中肝吸血虫病的最小肝性脑病：高患病率和与侧枝循环的关系
Iris Campos Lucas,Ana L Domingues,Norma Arteiro Filgueira et al.
Iris Campos Lucas et al.
Background: Hepatic encephalopathy (HE) is a poorly understood complication in hepatosplenic schistosomiasis (HSS), a neglected cause of non-cirrhotic portal hypertension. Although portosystemic shunts (PSS) are commonly ...
Interleukin-6/interleukin-10 ratio and immune dysregulation after radiofrequency ablation [0.03%]
射频消融后 interleukin-6/interleukin-10 比值与免疫失调的关系
Lei Pang,Di Tang,Wan-Lin Zhou et al.
Lei Pang et al.
Background: The immune response following radiofrequency ablation (RFA) is characterized by a dynamic interaction between proinflammatory and anti-inflammatory factors. An elevated ratio of interleukin (IL)-6 to IL-10 may...
Not always autoimmune hepatitis: Hepatic steatosis is associated with autoantibodies positivity in patients with hepatocellular dysfunction [0.03%]
并非总是自身免疫性肝炎：肝细胞功能障碍患者中的肝脂肪变与自身抗体阳性相关
Ana Isabel Ferreira,Mariana Costa Azevedo,Vitor Macedo Silva et al.
Ana Isabel Ferreira et al.
Background: Autoantibodies, including anti-nuclear antibodies (ANA), are typically present in autoimmune hepatitis (AIH), but may be detected in other liver conditions, including metabolic dysfunction-associated steatotic...
Educational video module for increasing treatment rates for alcohol use disorders in inpatients [0.03%]
针对住院患者的酒精使用障碍治疗率提升的教育视频模块
I Made Dwi Mertha Adnyana
I Made Dwi Mertha Adnyana
A study by Twohig et al evaluated the impact of an educational video module (EVM) on the treatment of alcohol use disorder (AUD) in hospitalized patients with alcohol-related liver disease (ALD). This single-center prospective study involve...
Jelena Roganovic,Ante Vidovic,Ana Dordevic
Jelena Roganovic
Contemporary treatment approaches have resulted in excellent cure rates for childhood cancer; however, these therapeutic advances are accompanied by adverse, long-term health outcomes, commonly referred to as late effects. Among these, late...
Fighting the epidemic of pediatric metabolic dysfunction-associated steatotic liver disease: Role of non-invasive diagnostics and early pharmacological intervention [0.03%]
对抗儿童代谢紊乱相关脂肪性肝病的流行：非侵入性诊断和早期药物干预的作用
Nicholas Beng-Hui Ng,Andrew Anjian Sng,James Guoxian Huang
Nicholas Beng-Hui Ng
The global rise in childhood obesity has made metabolic dysfunction-associated steatotic liver disease (MASLD) the leading cause of pediatric liver disease. Studies have consistently reported alarmingly high rates of advanced fibrosis in up...
Multidrug-resistant organism colonization in critically ill cirrhotic patients: Marker or mediator of mortality? [0.03%]
多重耐药菌定植在重症肝病患者中是死亡的标志还是介导因素？
Shi-San Bao,Yan Lu
Shi-San Bao
Bacterial infections are a key precipitant of acute decompensation and acute-on-chronic liver failure in cirrhotic patients. The rising prevalence of multidrug-resistant organisms complicates intensive care unit management, making colonizat...
Uncovering silent carriers: Hematological insights and viral burden in incidentally detected hepatitis B virus infection [0.03%]
沉默携带者的研究：偶然发现的慢性HBV感染患者的血液学特征和病毒学特征分析
Manisha M Ratnaparkhi,Chanda R Vyawahare,Parag J Ratnakar et al.
Manisha M Ratnaparkhi et al.
Background: Hepatitis B Virus (HBV) remains a global public health challenge, affecting over 296 million people, many of whom are asymptomatic. Incidentally diagnosed carriers provide a critical window for early intervent...
Evaluation methods of hepatic steatosis: From conventional techniques to emerging biomarkers [0.03%]
肝脂肪变性的评估方法：从传统技术到新兴生物标志物
Kengo Moriyama
Kengo Moriyama
Accurate assessment of hepatic steatosis is essential for diagnosing, staging, and monitoring metabolic dysfunction-associated steatotic liver disease. This review comprehensively overviews conventional and emerging hepatic steatosis evalua...
Current management strategies for sarcopenia and frailty in cirrhosis: Missing link in transplant candidacy [0.03%]
肝硬化的 sarcopenia 和衰弱的当前管理策略：移植候选人中的缺失环节
Manjeet Kumar Goyal,Rishi Chowdhary,Chirag Vohra et al.
Manjeet Kumar Goyal et al.
Sarcopenia and frailty are pervasive, interrelated syndromes in cirrhosis that worsen morbidity, quality of life, transplantation waitlist outcomes, and post-transplant survival. This review synthesized contemporary evidence on definitions,...